Nayoun Kim

1.5k total citations
40 papers, 1.1k citations indexed

About

Nayoun Kim is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Nayoun Kim has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Genetics and 12 papers in Hematology. Recurrent topics in Nayoun Kim's work include Mesenchymal stem cell research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Immune Cell Function and Interaction (9 papers). Nayoun Kim is often cited by papers focused on Mesenchymal stem cell research (16 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Immune Cell Function and Interaction (9 papers). Nayoun Kim collaborates with scholars based in South Korea, United States and United Kingdom. Nayoun Kim's co-authors include Seok‐Goo Cho, Keon-Il Im, Jung-Yeon Lim, Young-Sun Nam, Eun‐Jung Kim, Young‐Woo Jeon, Eunsol Lee, Eunjoo Jeon, Mi‐La Cho and Min-Jung Park and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Nayoun Kim

37 papers receiving 1.1k citations

Peers

Nayoun Kim
Nayoun Kim
Citations per year, relative to Nayoun Kim Nayoun Kim (= 1×) peers Veronica Lisi

Countries citing papers authored by Nayoun Kim

Since Specialization
Citations

This map shows the geographic impact of Nayoun Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayoun Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayoun Kim more than expected).

Fields of papers citing papers by Nayoun Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nayoun Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayoun Kim. The network helps show where Nayoun Kim may publish in the future.

Co-authorship network of co-authors of Nayoun Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Nayoun Kim. A scholar is included among the top collaborators of Nayoun Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nayoun Kim. Nayoun Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Nayoun, Keon-Il Im, Sung‐Yeon Cho, et al.. (2025). Effectiveness and Safety of Autologous Virus-Specific T-Cell Therapy for Persistent COVID-19 in People With Immunocompromise: A Clinical Trial Study. Clinical Infectious Diseases. 81(6). e510–e514.
2.
Im, Keon-Il, et al.. (2024). Mesenchymal stem cells preconditioned with a TLR5 agonist enhanced immunoregulatory effect through M2 macrophage polarization in a murine graft-versus-host disease model. International Journal of Medical Sciences. 21(9). 1649–1660. 2 indexed citations
3.
Kim, Nayoun, Gi June Min, Keon-Il Im, et al.. (2024). Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study. International Journal of Molecular Sciences. 25(12). 6731–6731. 6 indexed citations
4.
Im, Keon-Il, Nayoun Kim, Hye Won Lee, et al.. (2024). SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. International Journal of Molecular Sciences. 25(19). 10512–10512. 1 indexed citations
5.
Jeon, Young‐Woo, Jung-Yeon Lim, Keon-Il Im, Nayoun Kim, & Seok‐Goo Cho. (2022). BAFF blockade attenuates acute graft-versus-host disease directly via the dual regulation of T- and B-cell homeostasis. Frontiers in Immunology. 13. 995149–995149. 5 indexed citations
6.
Kim, Nayoun, Jong Min Lee, Eun‐Jee Oh, et al.. (2021). Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment. Frontiers in Immunology. 12. 751869–751869. 11 indexed citations
7.
Lim, Jung-Yeon, Taekyu Lim, Keon-Il Im, et al.. (2020). Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms. World Journal of Stem Cells. 12(9). 1032–1049. 25 indexed citations
8.
Im, Keon-Il, Young-Sun Nam, Nayoun Kim, et al.. (2019). Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis. Mucosal Immunology. 12(5). 1070–1081. 24 indexed citations
9.
Jeon, Young‐Woo, Jung-Yeon Lim, Keon-Il Im, et al.. (2018). Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model. Stem Cells and Development. 28(2). 129–140. 8 indexed citations
10.
Kim, Nayoun, Hyun‐Jung Sohn, Joo Hyun Oh, et al.. (2017). Infusions of Epstein–Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases. International Journal of Hematology. 107(5). 596–603. 6 indexed citations
11.
Kim, Nayoun, Young-Sun Nam, Keon-Il Im, et al.. (2017). Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System. Transfusion Medicine and Hemotherapy. 45(1). 13–22. 11 indexed citations
12.
Kim, Nayoun, Young-Sun Nam, Keon-Il Im, et al.. (2015). IL-21-Expressing Mesenchymal Stem Cells Prevent Lethal B-Cell Lymphoma Through Efficient Delivery of IL-21, Which Redirects the Immune System to Target the Tumor. Stem Cells and Development. 24(23). 2808–2821. 30 indexed citations
13.
Nam, Young-Sun, Nayoun Kim, Keon-Il Im, et al.. (2015). Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World Journal of Gastroenterology. 21(7). 2030–2039. 18 indexed citations
14.
Kim, Nayoun & Seok‐Goo Cho. (2015). Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications. International Journal of Hematology. 103(2). 129–137. 49 indexed citations
15.
Cho, Seok‐Goo, Nayoun Kim, Hyun‐Jung Sohn, et al.. (2015). Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs. Molecular Therapy. 23(8). 1401–1409. 68 indexed citations
16.
Kim, Nayoun, Young‐Woo Jeon, Young-Sun Nam, et al.. (2015). Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cells. Cytokine. 78. 22–26. 13 indexed citations
17.
Lee, Eunsol, Jung-Yeon Lim, Keon-Il Im, et al.. (2015). Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model. PLoS ONE. 10(9). e0138846–e0138846. 28 indexed citations
18.
Im, Keon-Il, Min-Jung Park, Nayoun Kim, et al.. (2014). Induction of Mixed Chimerism Using Combinatory Cell-Based Immune Modulation with Mesenchymal Stem Cells and Regulatory T Cells for Solid-Organ Transplant Tolerance. Stem Cells and Development. 23(19). 2364–2376. 18 indexed citations
19.
Kim, Eun‐Jung, et al.. (2014). Abstract 2720: In vitro evaluation of a novel chemotherapeutic agent, NecroX-7, in human Burkitt lymphoma cells. Cancer Research. 74(19_Supplement). 2720–2720. 1 indexed citations
20.
Kim, Eun‐Jung, Nayoun Kim, & Seok‐Goo Cho. (2013). The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation. Experimental & Molecular Medicine. 45(1). e2–e2. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026